Equine degenerative myeloencephalopathy: prevalence, impact, and management

Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy is an inherited neurodegenerative disorder affecting many horse breeds. Clinical signs include a symmetric ataxia and an abnormal stance at rest, similar to cervical vertebral compressive myelopathy, equine protozoal myeloencephalitis, and equine herpesvirus 1 myeloencephalopathy. This review will provide an update on the disease prevalence, management, impact, and ongoing research.

• Publication year

  2018

• Venue

  Veterinary medicine

• Publication date

  2018-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/VMRR.S148542PMID 30234005PMCID 6135079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy

  2018cited by this paper
• Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease

  2017cited by this paper
• Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization

  2016cited by this paper
• Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes.

  2016cited by this paper
• Concurrent Equine Degenerative Myeloencephalopathy and Equine Motor Neuron Disease in Three Young Horses

  2016cited by this paper
• Blood and Cerebrospinal Fluid α‐Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy

  2015influential reference
• Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse.

  2013cited by this paper
• The greater good

  2013cited by this paper
• Electrophysiological studies in American Quarter horses with neuroaxonal dystrophy.

  2012cited by this paper
• Evidence of Oxidative Injury of the Spinal Cord in 2 Horses With Equine Degenerative Myeloencephalopathy

  2012cited by this paper
• Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses.

  2011influential reference
• Equine degenerative myeloencephalopathy in Lusitano horses.

  2011cited by this paper
• Equine degenerative myeloencephalopathy in a horse in the UK

  2010cited by this paper
• Equine degenerative myeloencephalopathy in five Quarter Horses: clinical and neuropathological findings.

  2010cited by this paper
• Equine herpesvirus-1 consensus statement.

  2009cited by this paper
• Assessment of vitamin E concentrations in serum and cerebrospinal fluid of horses following oral administration of vitamin E.

  2008cited by this paper
• Vitamin E.

  2007cited by this paper
• Equine degenerative myeloencephalopathy in five Quarter Horses: clinical and neuropathological findings.

  2004cited by this paper
• Abnormal synaptic protein expression in two Arabian horses with equine degenerative myeloencephalopathy.

  2003cited by this paper
• Equine degenerative myeloencephalopathy.

  1997cited by this paper
• Neuroaxonal dystrophy in a two-year-old quarter horse filly.

  1996cited by this paper
• Equine Protozoal Myeloencephalitis: Antigen Analysis of Cultured Sarcocystis Neurona Merozoites

  1993cited by this paper
• Clinical, viral, and genetic evaluation of equine degenerative myeloencephalopathy in a family of Appaloosas.

  1991cited by this paper
• Serially determined plasma alpha-tocopherol concentrations and results of the oral vitamin E absorption test in clinically normal horses and in horses with degenerative myeloencephalopathy.

  1991cited by this paper
• Factors associated with the development of equine degenerative myeloencephalopathy.

  1990cited by this paper
• A retrospective study of nineteen ataxic horses.

  1989cited by this paper
• Plasma and liver copper values in horses with equine degenerative myeloencephalopathy.

  1989cited by this paper
• Serum profiles of vitamins A, E and D in mares and foals during different seasons.

  1988cited by this paper
• Equine degenerative myeloencephalopathy: a vitamin E deficiency that may be familial.

  1987cited by this paper
• Equine degenerative myeloencephalopathy.

  1987cited by this paper
• Genetic studies of neuraxonal dystrophy in the Morgan.

  1987cited by this paper
• Spinal cord disease in the horse.

  1978cited by this paper
• Equine degenerative myeloencephalopathy.

  1977cited by this paper
• Vitamin E.

  1959cited by this paper
• Vitamins in animal nutrition.

  1956cited by this paper

• Commercial cytokine assay on equine cerebrospinal fluid does not distinguish equine degenerative myeloencephalopathy from cervical vertebral stenotic myelopathy.

  2025cites this paper
• Vitamin E and Selenium-Related Manifestations of Muscle Disease.

  2025cites this paper
• Measurement of 8‐hydroxy‐2′‐deoxyguanosine in serum and cerebrospinal fluid of horses with neuroaxonal degeneration and other causes of proprioceptive ataxia

  2024cites this paper
• Cerebrospinal fluid and serum proteomic profiles accurately distinguish neuroaxonal dystrophy from cervical vertebral compressive myelopathy in horses

  2023cites this paper
• Genetic polymorphisms in vitamin E transport genes as determinants for risk of equine neuroaxonal dystrophy

  2023cites this paper
• Detection of equine herpesvirus-1 (EHV-1) in urine samples during outbreaks of equine herpesvirus myeloencephalopathy.

  2023cites this paper
• Pathologic Conditions of the Nervous System in Horses.

  2022cites this paper
• The Second Case of Non-Mosaic Trisomy of Chromosome 26 with Homologous Fusion 26q;26q in the Horse

  2022cites this paper
• Influence of Dietary Selenium on the Oxidative Stress in Horses

  2022cites this paper
• Equine Neuroaxonal Dystrophy and Degenerative Myeloencephalopathy.

  2022cites this paper
• Poor performance in the horse: Diagnosing the non‐orthopaedic causes

  2022cites this paper
• Vitamin E depletion is associated with subclinical axonal degeneration in juvenile horses.

  2022cites this paper
• Increased α‐tocopherol metabolism in horses with equine neuroaxonal dystrophy

  2021cites this paper
• Simultaneous quantification of vitamin E and vitamin E metabolites in equine plasma and serum using LC-MS/MS

  2021cites this paper
• Serum and cerebrospinal fluid phosphorylated neurofilament heavy protein concentrations in equine neurodegenerative diseases.

  2021cites this paper
• Postmortem diagnoses of spinal ataxia in 316 horses in California.

  2021cites this paper
• Accuracy of transcranial magnetic stimulation and a Bayesian latent class model for diagnosis of spinal cord dysfunction in horses

  2020cites this paper
• Genome-Wide Association Study and Subsequent Exclusion of ATCAY as a Candidate Gene Involved in Equine Neuroaxonal Dystrophy Using Two Animal Models

  2020cites this paper
• muscle fiber histopathology in horses.

  2019cites this paper
• Comparison of the clinical and radiographic appearance of the cervical vertebrae with histological and anatomical findings in an eight-month old warmblood stallion suffering from cervical vertebral stenotic myelopathy (CVSM)

  2019cites this paper
• Impact of alpha‐tocopherol deficiency and supplementation on sacrocaudalis and gluteal muscle fiber histopathology and morphology in horses

  2019cites this paper